Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day
- 1 August 1992
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 6 (4) , 479-485
- https://doi.org/10.1111/j.1365-2036.1992.tb00561.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Clinical tolerance to three 5‐aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazineAlimentary Pharmacology & Therapeutics, 1992
- Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.Gut, 1991
- Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazineAlimentary Pharmacology & Therapeutics, 1988
- Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Gut, 1980
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965